Asthma

The introduction of biologics such as dupilumab have opened avenues of care for patients with overlapping disease.

The biologic's indications for inflammatory diseases are greatly varied and still developing, and it owes some of that to recent advances in disease prognosis.

The AAAAI 2019 president explains why research is already dedicated toward improving investigative peanut allergens.

The Regeneron VP explains how dupilumab could possibly serve as a complimentary therapy to Aimmune's investigative food allergy therapy.

The Program Chair explains how the meeting has improved over 3 decades, and highlights his favorite sessions to come at the 2019 meeting.

Asthma risk and lung disease development can occur as easily and as frequently with smoking alternatives as it does with combustible cigarettes.

A new cohort from the Cleveland Clinic shows that the index could allow ICU clinicians to know whether a patient needs prone positioning or ECMO.

Both sex- and age-specific therapies could come to clinical asthma field in upcoming years.

Harvard University investigators found that both diacetyl and 2,3-pentanedione initiated changes in gene expressions that reduced the number of ciliated cells, and impacted how well they functioned.

Researchers determined that no relationship existed between haptoglobin polymorphism and frequent exacerbator status, though a negative one existed between exacerbator status and current smoking habits.

Nicotine was detectable on children’s hands, even when caregivers reported not smoking around the child.

Only a few studies have examined over-diagnosis, which investigators note is common if the diagnosis is based on symptoms alone or on a pre-bronchodilator spirometry.

The organization has provided five-year updates to its recommendation of therapies for adults with pulmonary arterial hypertension.

The 2 patient groups have often been grouped into a singular 'Latino' designation in previous pediatric asthma studies. These findings show it's not an accurate representation of either group.

The Mylan product has been approved as 3 different dosing strengths, inidicated for both asthma and COPD care.

UAB investigators sought to learn if neutrophil elastase exists in an exosomal form, and whether these exosomes could potentially bypass alpha1-antitrypsin inhibition to contribute to COPD.

Patients hospitalized for exacerbations due to asthma have a 29% longer stay if treated early with antibiotics.

Recent research suggests African Americans have a asthma-related mortality rate 10 times greater than non-Hispanic white children.

About 1 in 7 heart failure patients have COPD, which can lead to a 30% increase in risk of hospitalization and death.

Obese/overweight patients aged 12 to 25 years old with uncontrolled asthma reported no significant improvements in asthma control compared to patients treated with soy oil control.

Tobacco farm region physicians face the challenges of culture, law, and education in improving cessation.

Among differing genders and races, Columbia University investigators found females and Asian Americans are the most at-risk to have the undiagnosed condition.

As costs of treating COPD exacerbation continue to burden patients, investigators sought to determine a risk assessment tool that could lead to reduced costs.

Meta-analysis of other randomized controlled trials have shown that vitamin D supplementation reduces the risk of acute respiratory infections and exacerbations of asthma.

A recent study found a link between electronic nicotine delivery systems and asthma symptoms.